CMAI
DGX icon

Capital Management Associates Inc’s Quest Diagnostics DGX Stock Holding History

Capital Management Associates Inc’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.55M Buy
7,300
+1,400
+24% +$275K 0.31% 52
2026
Q1 		$1.16M Hold
5,900
– – 0.26% 58
2025
Q4 		$1.02M Buy
+5,900
New +$1.07M 0.23% 63

Other funds holding DGX

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
AIM
Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
BCAM
Boston Common Asset Management Boston, Massachusetts $1.69B AUM 28.29% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
JWM
JGP Wealth Management Bend, Oregon $1.11B AUM 35.22% 1-Year Est. Return

Capital Management Associates Inc's DGX Position: Q2 2026 in Review

Capital Management Associates Inc increased its Quest Diagnostics (DGX) stake by 24% in Q2 2026, buying an estimated $275K and bringing the position to 7,300 shares worth $1.55M. The position accounts for 0.31% of the portfolio, ranked #52.

Capital Management Associates Inc first reported a position in DGX in Q4 2025 and has held it in 3 quarters since. 253 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Capital Management Associates Inc held 7,300 shares of Quest Diagnostics worth $1.55M as of Q2 2026.
  • Capital Management Associates Inc bought 1,400 Quest Diagnostics shares in Q2 2026, an estimated $275K.
  • Quest Diagnostics made up 0.31% of Capital Management Associates Inc's portfolio in Q2 2026, its #52 holding.
  • Capital Management Associates Inc first reported a position in Quest Diagnostics in Q4 2025 and has held it in 3 quarters since.
  • 253 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Capital Management Associates Inc's 13F filing for Q2 2026, filed 22 Jul 2026.